The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
The discrepancy in HPV screening rates emphasizes a need for gender affirming options for sample collections. Considering the susceptibility and infection rate of transmasculine individuals and ...
"Advanced skincare treatments are gaining popularity among men as effective complements to their daily routines, favoured for their long-lasting results and minimal downtime. Bio remodelling ...